- Home
- IRBT vs CDXC Comparison
IRBT vs CDXC Comparison
Compare IRBT & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRBT
- CDXC
- Stock Information
- Founded
- IRBT 1990
- CDXC 1999
- Country
- IRBT United States
- CDXC United States
- Employees
- IRBT N/A
- CDXC N/A
- Industry
- IRBT Consumer Electronics/Appliances
- CDXC Medicinal Chemicals and Botanical Products
- Sector
- IRBT Consumer Discretionary
- CDXC Health Care
- Exchange
- IRBT Nasdaq
- CDXC Nasdaq
- Market Cap
- IRBT 257.0M
- CDXC 264.4M
- IPO Year
- IRBT N/A
- CDXC N/A
- Fundamental
- Price
- IRBT $6.70
- CDXC $6.67
- Analyst Decision
- IRBT Hold
- CDXC Strong Buy
- Analyst Count
- IRBT 2
- CDXC 2
- Target Price
- IRBT $13.00
- CDXC $8.00
- AVG Volume (30 Days)
- IRBT 1.1M
- CDXC 2.5M
- Earning Date
- IRBT 11-06-2024
- CDXC 10-31-2024
- Dividend Yield
- IRBT N/A
- CDXC N/A
- EPS Growth
- IRBT N/A
- CDXC N/A
- EPS
- IRBT N/A
- CDXC 0.02
- Revenue
- IRBT $817,355,000.00
- CDXC $91,668,000.00
- Revenue This Year
- IRBT N/A
- CDXC $15.33
- Revenue Next Year
- IRBT $4.94
- CDXC $20.08
- P/E Ratio
- IRBT N/A
- CDXC $344.07
- Revenue Growth
- IRBT N/A
- CDXC 9.95
- 52 Week Low
- IRBT $5.83
- CDXC $1.32
- 52 Week High
- IRBT $42.14
- CDXC $7.08
- Technical
- Relative Strength Index (RSI)
- IRBT 39.99
- CDXC 81.24
- Support Level
- IRBT $6.55
- CDXC $3.39
- Resistance Level
- IRBT $10.60
- CDXC $7.08
- Average True Range (ATR)
- IRBT 0.74
- CDXC 0.46
- MACD
- IRBT -0.15
- CDXC 0.36
- Stochastic Oscillator
- IRBT 9.01
- CDXC 90.06
About IRBT iRobot Corporation
iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.